Want to join the conversation?
Janssen-Cilag International, a $JNJ company, received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA). This recommends marketing authorization in the European Union for Stelara (ustekinumab) to treat moderately to severely active Crohn's disease.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.